Event Brief
Lilly revenue rises 48% on strong GLP-1 demand
Filed: Aug 05, 2026 at 9:06 AM ET
Summary: Eli Lilly reported sales growth driven by higher-than-expected demand for Mounjaro and Zepbound.
WHO: Eli Lilly
WHAT: Lilly reported revenue up 48%, driven by demand for its GLP-1 drugs Mounjaro and Zepbound
WHEN: Aug 05, 2026 at 8:01 AM ET
WHERE: USA
WHY: Higher-than-expected demand for Mounjaro and Zepbound drove sales.
ℹ️ This event is analyzed using pattern arcs, velocity indicators, and source analysis in our MI Console.
Know more. Read less.
The BriefBrief follows the story, so you don't have to read every article. See what happened, how it changed, and where it came from, all in one place.
Same format. Every time.
See how stories unfold →